DART has been registered with ISRCTN, using ID 13720905
This includes a Plain English summary under the title “Providing data so computer systems can help with the early identification of lung diseases, leading to more rapid treatment and better survival rates”.
Registration with ISRCTN is the first step towards trial transparency and the future dissemination of health research outcomes. Its key aim is to ensure that all healthcare decisions are informed by all of the available evidence, thus, overcoming publication bias and selective reporting. Registration provides opportunities for collaboration and reduces duplication of research efforts; it also improves awareness of trials for clinicians, researchers, patients and the public.
Celebrate Doncaster LHC’s success
May 4, 2022
The Doncaster programme has been operational since mid-March 2021 and in the first year 11,857 lung health check calls and more…
Optellum attains CE marking in Europe
April 5, 2022
Approvals and adoption
March 2, 2022
GE Healthcare and Optellum join forces to advance Lung Cancer Diagnosis with Artificial Intelligence
November 29, 2021